Awakn Life Sciences Corp.: Awakn Life Sciences Reports Q4 20

Annual Revenue Increased by 534%
Toronto, Ontario--(Newsfile Corp. - April 28, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing therapeutics

Related Keywords

Norway , Toronto , Ontario , Canada , London , City Of , United Kingdom , Exeter , Devon , Oslo , United States , Canadian , Gordo Whittaker , Catalent Zydis , Anthony Tennyson , Linkedin Facebook , Awakn Bristol , Newsfile Corp , National Institute For Health , Awakn Life Sciences Corp , Research Council , University Of Exeter , International Financial Reporting Standards , United Kingdom National Health Services , Awakn Life Sciences , Regulatory Agency , Care Research , Annual Revenue Increased , Life Sciences , Alcohol Use Disorder , Oral Disintegrating Tablet , Operational Updates , Including Subsequent Updates , Innovation Passport , Innovative Licensing , Access Pathway , Severe Alcohol Use , National Health Services , National Institute , Medical Research Council , Clinics Trondheim , Corporate Highlights , Including Subsequent Developments , Financial Highlights , United States Securities Act , Awakn Life , Awakn , Life , Ciences , Orp , Reports , 023 , Nnual , Results ,